DD vs DOW: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of October 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. DD and DOW share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined DD and DOW exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

DuPont de Nemours is a diversified specialty chemicals and materials company. After the 2019 split of DowDuPont into three companies (Dow, DuPont, Corteva), DuPont retained the specialty materials businesses. In 2024 it announced a plan to separate into three companies (Electronics, Water and Industrial); the plan was later narrowed, and the step that happened was the spin-off of the electronics business as Qnity Electronics, which DuPont announced as complete in late 2025. DuPont now describes itself as focused on healthcare, water, construction and industrial markets, and its best-known products include Tyvek protective and medical packaging materials.

Full DD guide

Dow Inc. is a global materials-science company that makes plastics, industrial chemicals, and specialty materials. It operates in three segments: Packaging & Specialty Plastics (polyethylene and packaging resins for films, containers, and hygiene products), Industrial Intermediates & Infrastructure (ethylene-oxide and propylene-oxide derivatives used in coatings, cleaning, construction, and polyurethanes), and Performance Materials & Coatings (silicones, acrylics, and cellulosics for consumer, infrastructure, and mobility markets). Dow makes money by converting oil-and-gas feedstocks into ethylene and downstream chemicals at enormous scale and selling them worldwide, so its margins depend heavily on the spread between feedstock and energy costs and the market price of its commodity products. It employs about 32,800 people.

Full DOW guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• DD drivers: Life after the Qnity spin-off; Healthcare and protective materials.
• DOW drivers: Chemical-cycle recovery; Restructuring and cost reduction.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Separation aftereffects: GAAP results still carry separation and restructuring costs, and the payout ratio on GAAP earnings is about 81%, so the dividend depends on the adjusted earnings recovery holding. For DOW, the dominant risk is commodity-cycle cyclicality: Dow's plastics and chemicals sell into global markets at prices it does not control, so a prolonged downturn, weak industrial demand, or continued China-led oversupply can keep margins compressed and earnings in the red, as the losses from late 2025 through the first quarter of 2026 showed.

Pick DD if you believe its drivers more; DOW if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the DD and DOW guides.

DD. The trailing P/E of about 36x is distorted by separation charges; on forward estimates DuPont trades near 16.5x, a typical specialty-materials multiple now that the electronics business trades separately as Qnity. The average analyst target of about $165 sits above the price, though several firms cut targets in October 2026 ahead of the November 3 third-quarter report.

DOW. For a cyclical chemicals producer, headline multiples mean less than where the chemical cycle sits, because a depressed or negative earnings base distorts P/E. Dow trades at about 0.5 times sales and about 17 times forward earnings, and the trailing P/E is undefined because the last twelve months still show a loss. The investment question centers on whether the second-quarter 2026 rebound proves durable, with the October 22 report the next test, rather than on any single quarter's number.

Headline figures (approximate, October 2026): DD shows revenue (ttm, post-qnity) ~$7.0 billion, +~4% yoy in Q2 2026, q2 2026 adjusted eps $1.88 vs ~$1.76 expected, operating margin (ttm) ~14%, net income (ttm) ~$306 million GAAP (separation costs); EPS ~$3.69; DOW shows revenue (ttm) ~$41.3 billion, q2 2026 revenue ~$12.1 billion, up ~20% year over year, net income (ttm) ~-$1.3 billion (loss); Q2 2026 net income ~$721 million, eps (q2 2026) $1.44 vs $1.28 estimate.

DD and DOW are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined DD and DOW exposure against your real portfolio. It is not an investment adviser.